Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9415116
Compositions and methods for delivering inhibitory oligonucleotides
granted -
US 9415099
Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conserved regions
granted -
US 9415105
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 9409994
High-affinity monoclonal antibodies to glypican-3 and use thereof
granted -
US 9409956
Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof
granted -
US 9408896
Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
granted -
US 9408901
Compositions, methods and uses for dengue virus serotype-4 constructs
granted -
US 9409992
Mesothelin domain-specific monoclonal antibodies and use thereof
granted -
US 9402820
Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors
granted -
US 9403872
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
granted -
US 9402889
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted -
US 9399625
Acridone compounds
granted -
US 9399672
Hepatitis C virus neutralizing antibody
granted -
US 9394352
Immunogenic POTE peptides and methods of use
granted -
US 9394364
Human monoclonal antibodies specific for glypican-3 and use thereof
granted -
US 9393271
GHRH agonists for islet cell transplantation and function and the treatment of diabetes
granted -
US 9394316
Inhibitors of the plasmodial surface anion channel as antimalarials
granted -
US 9394358
Gene signature for predicting prognosis of patients with solid tumors
granted -
US 9388222
Modified Pseudomonas exotoxin A
granted -
US 9387224
Treatment of specific cardiovascular conditions with nitrite
granted -
US 9388221
Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies
granted -
US 9382302
Lutzomyia longipalpis polypeptides and methods of use
granted -
US 9382311
HIV-1 broadly neutralizing antibodies
granted -
US 9375438
Inhibitors of NCCa-ATP channels for therapy
granted